RESUMO
INTRODUCTION: CoV-2 infection generates a pro-inflammatory state, which conditions the formation of thrombi that can affect any system. Multi-organ dysfunction is a cause of death, mesenteric ischemia in COVID 2019 patients reported is 1.9-4%. DESCRIPTION OF THE CASE: We present the case of a 73-year-old male patient who started with severe SARS-CoV-2 and arterial-type intestinal ischemia, necrosis of 3 m of the small intestine, based on SCARE 2020 guide. DISCUSSION: Complications secondary to thrombosis are as follows; myocardial infarction 1.1%, ischemic cerebral events, 2.5-3.7%, microvascular thrombosis including mesenteric ischemia in less than 1% of cases. In patients with mesenteric ischemia the reported postoperative mortality is 23.8% of patients especially during the first 30 days. CONCLUSION: Intestinal thrombosis in patients with SARS-CoV-2 increases mortality.
RESUMO
INTRODUCTION: Inflammatory myofibroblastic tumors are neoplasms that occur infrequently, mainly affects children and young adults. It is an intermediate grade fibrotic multinodular neoplasm. DESCRIPTION OF THE CASE: We present the case of a 47-year-old female patient, who underwent emergency umbilical hernioplasty, later developed intestinal obstruction secondary to an inflammatory myofibroblastic tumor. DISCUSSION: In 1939 Brunn described it for the first time, later in 1954 Umiker named it "Inflammatory Myofibroblastic Tumor". The symptoms are nonspecific. In 15 to 40% of patients they are asymptomatic. Cells positive for actin, smooth muscle, vimentin and desmin, in 3367% of cases the cells are positive for ALK, which is present in some malignant lesions. The recommended treatment is radical resection. CONCLUSION: The diagnosis is established by histopathological study, surgery is the cornerstone of treatment.
